These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 6941858

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Nucleotide pools and mutagenic effects of alkylating agents in wild-type and APRT-deficient Friend erythroleukaemia cells.
    Amara FM, Wilkinson YA, Ward PE, Thompson CC, McKenna PG.
    Mutat Res; 1991 Jan; 246(1):151-7. PubMed ID: 1986259
    [Abstract] [Full Text] [Related]

  • 8. Cell killing and mutagenesis by alkylating agents and UV irradiation in wild-type and deoxycytidine-kinase-deficient Friend murine leukaemia cells.
    McKenna PG, Boullier BA.
    Mutagenesis; 1988 Mar; 3(2):153-5. PubMed ID: 3288838
    [Abstract] [Full Text] [Related]

  • 9. Bleomycin-induced DNA damage and repair in wild-type and thymidine kinase-deficient Friend mouse erythroleukaemia cells.
    Sweetman SF, McKenna PG, McKelvey-Martin VJ.
    Br J Biomed Sci; 1995 Dec; 52(4):257-65. PubMed ID: 8555779
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of thymidine kinase and methyltransferase deficiency on mutagenesis in a human lymphoblastoid cell line.
    Best CJ, McKelvey-Martin VJ, McKenna PG.
    Mutat Res; 1994 Sep 01; 309(2):235-42. PubMed ID: 7520981
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The thymidine-kinase locus of Friend erythroleukaemic cells. 1. Mutation rates and properties of mutants.
    McKenna PG, Hickey I.
    Mutat Res; 1981 Jan 01; 80(1):187-99. PubMed ID: 6937730
    [Abstract] [Full Text] [Related]

  • 14. Derivation of TK- clones from revertant TK+ mammalian cells.
    Roufa DJ, Sadow BN, Caskey CT.
    Genetics; 1973 Nov 01; 75(3):515-30. PubMed ID: 4359755
    [Abstract] [Full Text] [Related]

  • 15. Synergism between U.V. and thymidine treatments in the induction of cytogenetic damage in wild-type Friend erythroleukaemia cells.
    McKelvey VJ, McKenna PG.
    Leuk Res; 1988 Nov 01; 12(2):167-71. PubMed ID: 3162754
    [Abstract] [Full Text] [Related]

  • 16. Azacytidine induces reversion of thymidine kinase deficiency in Friend erythroleukemia cells.
    Hickey I, Jones S, O'Neill K.
    Exp Cell Res; 1986 May 01; 164(1):251-5. PubMed ID: 2420626
    [Abstract] [Full Text] [Related]

  • 17. Bromodeoxyuridine resistance: thymidine transport and phosphorylation in Friend leukemia cells.
    Keller P, Zownir O, Morrow J.
    Mutat Res; 1984 Mar 01; 126(1):53-62. PubMed ID: 6583506
    [Abstract] [Full Text] [Related]

  • 18. The mismatch repair protein, hMLH1, mediates 5-substituted halogenated thymidine analogue cytotoxicity, DNA incorporation, and radiosensitization in human colon cancer cells.
    Berry SE, Garces C, Hwang HS, Kunugi K, Meyers M, Davis TW, Boothman DA, Kinsella TJ.
    Cancer Res; 1999 Apr 15; 59(8):1840-5. PubMed ID: 10213489
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.